Cargando…

Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein

BACKGROUND: Risk assessment in clinical practice plays an important role in classifying population for appropriate preventive medicine for each category. Several multivariable risk predictor algorithms and inflammatory biomarkers are developed for assessing risk for cardiovascular diseases (CVDs). W...

Descripción completa

Detalles Bibliográficos
Autores principales: Alaei Faradonbeh, Nazanin, Nikaeen, Fariborz, Akbari, Mojtaba, Almasi, Naser, Vakhshoori, Mehrbod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312566/
https://www.ncbi.nlm.nih.gov/pubmed/30627192
http://dx.doi.org/10.22122/arya.v14i4.1685
_version_ 1783383790033305600
author Alaei Faradonbeh, Nazanin
Nikaeen, Fariborz
Akbari, Mojtaba
Almasi, Naser
Vakhshoori, Mehrbod
author_facet Alaei Faradonbeh, Nazanin
Nikaeen, Fariborz
Akbari, Mojtaba
Almasi, Naser
Vakhshoori, Mehrbod
author_sort Alaei Faradonbeh, Nazanin
collection PubMed
description BACKGROUND: Risk assessment in clinical practice plays an important role in classifying population for appropriate preventive medicine for each category. Several multivariable risk predictor algorithms and inflammatory biomarkers are developed for assessing risk for cardiovascular diseases (CVDs). We aimed to depict a picture of the cardiovascular risk profiles in the Iranian population with diabetes mellitus (DM) through three risk predictors for the first time, as the patients with DM have an increased risk for CVDs. METHODS: In this cross-sectional study, the sample size consisted of 418 patients with DM from Diabetes Clinic of Shariati hospital, Isfahan, Iran, in February to July, 2014. We collected the latest information, and then calculated the 10-year CVD risk using Framingham risk score (FRS) and atherosclerotic cardiovascular disease (ASCVD) risk score; while high-sensitivity C-reactive protein (hs-CRP) was measured for them based on their physicians' prescription. Finally, all data were analyzed using SPSS software. RESULTS: The mean 10-year risk prediction of CVDs in the 30- to 74-year-old Iranian patients with DM was high in all three predictors based on their cut-off points, 16.31%, 12.39%, and 3.46 mg/l for FRS, ASCVD risk score, and hs-CRP level, respectively. Although the mean FRS and ASCVD risk scores were significantly higher among men than women (P < 0.0500), the mean hs-CRP level was slightly lower in men than women (P > 0.0500). CONCLUSION: Mean FRS and ASCVD risk scores and hs-CRP in patients were high, and a considerable proportion of patients with DM in our study were at intermediate and high risk for CVDs in the next 10 years. Future cohort studies would investigate the accuracy of different predictors in upcoming years, and also help to derive a specific model or recalibrate existing predictors with characteristic of Iranian populations and specific target groups.
format Online
Article
Text
id pubmed-6312566
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-63125662019-01-09 Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein Alaei Faradonbeh, Nazanin Nikaeen, Fariborz Akbari, Mojtaba Almasi, Naser Vakhshoori, Mehrbod ARYA Atheroscler Original Article BACKGROUND: Risk assessment in clinical practice plays an important role in classifying population for appropriate preventive medicine for each category. Several multivariable risk predictor algorithms and inflammatory biomarkers are developed for assessing risk for cardiovascular diseases (CVDs). We aimed to depict a picture of the cardiovascular risk profiles in the Iranian population with diabetes mellitus (DM) through three risk predictors for the first time, as the patients with DM have an increased risk for CVDs. METHODS: In this cross-sectional study, the sample size consisted of 418 patients with DM from Diabetes Clinic of Shariati hospital, Isfahan, Iran, in February to July, 2014. We collected the latest information, and then calculated the 10-year CVD risk using Framingham risk score (FRS) and atherosclerotic cardiovascular disease (ASCVD) risk score; while high-sensitivity C-reactive protein (hs-CRP) was measured for them based on their physicians' prescription. Finally, all data were analyzed using SPSS software. RESULTS: The mean 10-year risk prediction of CVDs in the 30- to 74-year-old Iranian patients with DM was high in all three predictors based on their cut-off points, 16.31%, 12.39%, and 3.46 mg/l for FRS, ASCVD risk score, and hs-CRP level, respectively. Although the mean FRS and ASCVD risk scores were significantly higher among men than women (P < 0.0500), the mean hs-CRP level was slightly lower in men than women (P > 0.0500). CONCLUSION: Mean FRS and ASCVD risk scores and hs-CRP in patients were high, and a considerable proportion of patients with DM in our study were at intermediate and high risk for CVDs in the next 10 years. Future cohort studies would investigate the accuracy of different predictors in upcoming years, and also help to derive a specific model or recalibrate existing predictors with characteristic of Iranian populations and specific target groups. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2018-07 /pmc/articles/PMC6312566/ /pubmed/30627192 http://dx.doi.org/10.22122/arya.v14i4.1685 Text en © 2018 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Alaei Faradonbeh, Nazanin
Nikaeen, Fariborz
Akbari, Mojtaba
Almasi, Naser
Vakhshoori, Mehrbod
Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
title Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
title_full Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
title_fullStr Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
title_full_unstemmed Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
title_short Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
title_sort cardiovascular disease risk prediction among iranian patients with diabetes mellitus in isfahan province, iran, in 2014, by using framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive c-reactive protein
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312566/
https://www.ncbi.nlm.nih.gov/pubmed/30627192
http://dx.doi.org/10.22122/arya.v14i4.1685
work_keys_str_mv AT alaeifaradonbehnazanin cardiovasculardiseaseriskpredictionamongiranianpatientswithdiabetesmellitusinisfahanprovinceiranin2014byusingframinghamriskscoreatheroscleroticcardiovasculardiseaseriskscoreandhighsensitivecreactiveprotein
AT nikaeenfariborz cardiovasculardiseaseriskpredictionamongiranianpatientswithdiabetesmellitusinisfahanprovinceiranin2014byusingframinghamriskscoreatheroscleroticcardiovasculardiseaseriskscoreandhighsensitivecreactiveprotein
AT akbarimojtaba cardiovasculardiseaseriskpredictionamongiranianpatientswithdiabetesmellitusinisfahanprovinceiranin2014byusingframinghamriskscoreatheroscleroticcardiovasculardiseaseriskscoreandhighsensitivecreactiveprotein
AT almasinaser cardiovasculardiseaseriskpredictionamongiranianpatientswithdiabetesmellitusinisfahanprovinceiranin2014byusingframinghamriskscoreatheroscleroticcardiovasculardiseaseriskscoreandhighsensitivecreactiveprotein
AT vakhshoorimehrbod cardiovasculardiseaseriskpredictionamongiranianpatientswithdiabetesmellitusinisfahanprovinceiranin2014byusingframinghamriskscoreatheroscleroticcardiovasculardiseaseriskscoreandhighsensitivecreactiveprotein